Percheron Therapeutics Limited (ASX:PER)

Australia · Delayed Price · Currency is AUD

0.0070

0.00 (0.00%)

Mar 4, 2026, 2:06 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Unallocated	371.09K	616.18K	384.92K	-	-
Unallocated Growth	-39.77%	60.08%	-	-	-
ATL1102	1.43M	2.35M	1.58M	1.78M	577.76K
ATL1102 Growth	-39.20%	48.88%	-11.14%	207.72%	-11.59%
Total	1.80M	2.97M	1.96M	1.78M	577.76K
Total Growth	-39.32%	51.07%	10.51%	207.72%	-13.59%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Australia	1.43M	2.35M	1.96M	1.78M	577.76K
Australia Growth	-39.22%	19.74%	10.51%	207.72%	-13.56%
Total	1.43M	2.35M	1.96M	1.78M	577.76K
Total Growth	-39.22%	19.74%	10.51%	207.72%	-13.56%

Source: S&P Global Market Intelligence.